Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- Check7 days agoChange DetectedThe IMPAHCT page now marks the study as terminated and adds a results summary. It states that AV-101 (inhaled imatinib) did not prove efficacy at any tested dose in PAH.SummaryDifference0.0%

- Check14 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check22 days agoChange DetectedIMPAHCT study status updated to Terminated. The page notes that AV-101 (inhaled imatinib) did not demonstrate efficacy at the tested doses.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2; this appears to be a minor site maintenance update with no changes to study data or page functionality.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a minor site update with no changes to study content or user-facing information.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page shows a new Revision: v3.4.1 label, replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.